HCV Advocate LogoHCV Advocate Logo
Contact Us Site Map Resources en Espanol
For living Positivley. Being Well
About Hepatitis
News Updates
News Review
Conference reports
News Articles
HCV Advocate Newsletter
Sign up for Email Updates
Community & Support
Resource Library
About Hcsp
 
Bookmark and Share
News Review

Top News
from AASLD 2013

AASLD 2013: Multisite randomized trial of an Integrated Care (IC) model for HCV patients with psychiatric and substance use co-morbidities: final results of impact on treatment initiation
Nov 8

AASLD 2013: Evolution of liver fibrosis in HIV/HCV-coinfected patients: impact of anti-HCV therapy in patients with different grades of liver stiffness
Nov 8

AASLD 2013: Evolution of liver fibrosis in HIV/HCV-coinfected patients: impact of anti-HCV therapy in patients with different grades of liver stiffness
Nov 8

AASLD 2013: AASLD: Boehringer Ingelheim—Interferon-Free Study
Nov 8

AASLD 2013: Gamma-GT levels may predict HCC risk in noncirrhotic patients after SVR
Nov 8

AASLD 2013: Long term survival of liver fibrosis after virological cure (SVR) in patients with chronic hepatitis C (CHC): The avenue of the scars?
Nov 6

AASLD:2013 Telaprevir Interferes with Levothyroxine Treatment of Hypothyroidism
Nov 6

AASLD 2013: Changing Demographics of Hepatitis C Genotype 1 Patient Population in Care
Nov 6

AASLD 2013: Evaluation of the Long-Term Health Outcomes Associated with Earlier Versus Later Initiation of Treatment in Previously Untreated Patients with Chronic Hepatitis C Virus Genotype 1 Infection
Nov 6

AASLD 2013: Therapeutic Outcome in 6198 Interferon-Naive Egyptian Patients with Chronic Hepatitis C genotype-4: A Real Experience
Nov 6

AASLD 2013: Long-term clinical outcome of Mexican patients with Chronic Hepatitis C infection after Sustained Virological Response to antiviral therapy
Nov 6

AASLD 2013: Interferon-Free HCV Tx Benefits Mentally Ill
Nov 5

AASLD 2013: HIV/HCV Coinfection—Phase 3 Study Results of Sofosbuvir plus Ribavirin
Nov 5

AASLD 2013: Hepatitis C Screening Rates at a Single Center after the Release of a CDC Recommendation to Screen All Adults Born Between 1945 and 1965
Nov 4

AASLD 2013: Diagnosis and Treatment of HCV-related mixed cryoglobulinemia over the last decade at a Liver Referral Center
Nov 4

AASLD 2013: First Study of Its Kind Shows That All-oral Treatment Regimen Prevents Hepatitis C Recurrence in Liver Transplant Recipients Who Received Allografts
Nov 4

AASLD 2013: Higher Sustained Virologic Response Achievable in Liver Transplant Recipients with Hepatitis C Treated with Protease Inhibitor Triple Therapy
Nov 4

AASLD 2013: Evaluation of the Long-Term Health Outcomes Associated with Earlier Versus Later Initiation of Treatment in Previously Untreated Patients with Chronic Hepatitis C Virus Genotype 1 Infection
Nov 3

AASLD 2013: AbbVie: Cure Rates = 90 – 95%
Nov 3

AASLD 2013: Merck's Study = 96% to 100% Cure Rates
Nov 3

AASLD 2013: Faldaprevir plus PEG/RBV Phase 3 Results
Nov 3

AASLD 2013: Successful Introduction of Telemedicine to Improve Access to Hepatology Specialty Services for Veterans with Liver Disease
Nov 2

AASLD 2013: Veterans Affairs Research Supports CDC Recommendation to Screen Baby Boomers for Hepatitis C
Nov 2

AASLD 2013: Assessing the Global and Regional Burden of Liver Disease
Nov 2

AASLD 2013: Stigma in Cirrhosis Associated with Diminished Quality of Life, Social Support, Healthcare Seeking and Depression
Nov 2

AASLD 2013: HCV positive injection drug users and linkage to care: a missed opportunity
Nov 2

AASLD 2013: Mortality due to Chronic Liver Disease among American Indians and Alaska Natives in the United States, 1999–2009
Nov 2

AASLD: HIV/HCV Coinfection – Phase 3 Studies: Sofosbuvir All Oral Combination therapy Achieves High Cure Rates
Nov 2

AASLD:New Sofosbuvir study for HCV Genotype 3 Produces High Cure Rates
Nov 2

 

 


About Hepatitis | News Updates | Community & Support | Resource Library | About HCSP | Contact Us | Site Map | Recursos en Español | Home

Hepatitis C Support Project

© 2013 Hepatitis C Support Project

Medical  Writers' Circle
Fact Sheets